ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för mirodenafil. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

27 träffar

Bibliografisk träff 2021-01-01

Phosphodiesterases 5 Inhibitors and Erectile Dysfunction Recovery after Pelvic Surgery: Future Perspectives for New Drugs and New Formulations.

Lombardo R, Tema G, De Nunzio C.

Curr Drug Targets · systematic review; journal article · DOI 10.2174/1389450121666200925145347

Bibliografisk träff 2020-05-09

Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis.

Madeira CR, Tonin FS, Fachi MM, Borba HH, Ferreira VL, Leonart LP, Bonetti AF, Moritz RP, Trindade ACLB, Gonçalves AG, Fernandez-Llimos F, Pontarolo R.

World J Urol · systematic review; network meta-analysis; journal article · DOI 10.1007/s00345-020-03233-9

Bibliografisk träff 2016-02-23

Drug Concentration in Rat Plasma, Bladder, and Prostate After Mirodenafil Administration in a Chronic Pelvic Ischemia Model.

Shim JS, Bae JH.

Urology · journal article · DOI 10.1016/j.urology.2016.02.017

Bibliografisk träff 2016-01-19

A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction.

Cho MC, Paick JS.

Ther Adv Urol · review-article; review; journal article · DOI 10.1177/1756287215625408

Bibliografisk träff 2015-03-26

Mirodenafil prevents bladder dysfunction induced by chronic bladder ischemia in rats.

Choi H, Bae JH, Shim JS, Park JY, Moon du G, Lee JG.

Int Neurourol J · research-article; journal article · DOI 10.5213/inj.2015.19.1.19

Bibliografisk träff 2014-12-29

The efficacy of mirodenafil for chronic prostatitis/chronic pelvic pain syndrome in middle-aged males.

Kong do H, Yun CJ, Park HJ, Park NC.

World J Mens Health · research-article; journal article · DOI 10.5534/wjmh.2014.32.3.145

Bibliografisk träff 2014-08-27

Re: Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials.

Li J, Shi Q, Wei Q, Han P.

Aging Male · letter; comment · DOI 10.3109/13685538.2014.954994

Bibliografisk träff 2014-04-25

Mirodenafil for the treatment of erectile dysfunction: a systematic review of the literature.

Park HJ, Moon KH, Lee SW, Lee WK, Kam SC, Lee JH, Park NC.

World J Mens Health · review-article; review; journal article · DOI 10.5534/wjmh.2014.32.1.18

Bibliografisk träff 2013-11-12

Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials.

Du W, Li J, Fan N, Shang P, Wang Z, Ding H.

Aging Male · meta-analysis; research support, non-u.s. gov't; journal article · DOI 10.3109/13685538.2013.858114

Bibliografisk träff 2013-08-12

Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study.

Lee WK, Lee SH, Cho ST, Lee YS, Oh CY, Yoo C, Cho JS, Lee SK, Yang DY.

J Sex Med · multicenter study; randomized controlled trial; journal article · DOI 10.1111/jsm.12287

Bibliografisk träff 2013-05-14

Effects of mirodenafil, a phosphodiesterase-5 inhibitor, on female rat bladder in a partial bladder outlet obstruction model: physiological and immunohistochemical aspects.

Kang JY, Kim EK, Kim KM.

Korean J Urol · research-article; journal article · DOI 10.4111/kju.2013.54.5.339

Bibliografisk träff 2013-02-06

High-sensitive LC-MS/MS method for the simultaneous determination of mirodenafil and its major metabolite, SK-3541, in human plasma: application to microdose clinical trials of mirodenafil.

Cho DY, Bae SH, Shon JH, Bae SK.

J Sep Sci · clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1002/jssc.201200919

Bibliografisk träff 2013-01-10

Efficacy and safety of the simultaneous administration of mirodenafil and an α-blocker in men with BPH-LUTS: a multicenter open-label prospective study.

Bang WJ, Oh CY, Yoo C, Cho JS, Yang DY, Lee DH, Lee SH, Chung BH.

Int J Impot Res · research support, non-u.s. gov't; multicenter study; journal article · DOI 10.1038/ijir.2012.44

Bibliografisk träff 2012-12-01

Assessment of the influence of severe renal impairment on the pharmacokinetics of mirodenafil in Korean male volunteers.

Noh YH, Lim HS, Cho SH, Ghim JL, Choe S, Jung JA, Kim MJ, Kim YH, Jin SJ, Kim SB, Park JS, Lee SK, Yang WS, Chang JW, Lee B, Bae KS.

Int J Clin Pharmacol Ther · research support, non-u.s. gov't; journal article · DOI 10.5414/cp201721

Bibliografisk träff 2012-09-24

Safety and efficacy of once daily administration of 50 mg mirodenafil in patients with erectile dysfunction: a multicenter, double-blind, placebo controlled trial.

Chung JH, Kang DH, Oh CY, Chung JM, Lee KS, Kim TH, Moon KH, Lee W, Cho JM, Lee SW.

J Urol · comparative study; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.juro.2012.08.243

Bibliografisk träff 2012-08-24

Assessment of the effect of mirodenafil on the hemodynamics of healthy male Korean volunteers administered tamsulosin: a randomized, double-blind, placebo-controlled, 2-period crossover study.

Gu N, Kim J, Lim KS, Shin KH, Kim TE, Lee B, Shin SG, Jang IJ, Yu KS.

Clin Ther · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.clinthera.2012.08.002

Bibliografisk träff 2012-06-12

Validated LC-MS/MS method for the determination of mirodenafil in rat plasma and its application to a comparative pharmacokinetic study of the free base and hydrochloride salt forms of mirodenafil.

Kim TK, Yoo HH, Park JH.

Arzneimittelforschung · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1055/s-0032-1312665

Bibliografisk träff 2011-04-11

Effects of Ginkgo biloba extracts with mirodenafil on the relaxation of corpus cavernosal smooth muscle and the potassium channel activity of corporal smooth muscle cells.

Kim JJ, Han DH, Lim SH, Kim TH, Chae MR, Chung KJ, Kam SC, Jeon JH, Park JK, Lee SW.

Asian J Androl · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/aja.2010.184

Bibliografisk träff 2010-11-29

Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, in spontaneously or DOCA-salt-induced hypertensive rats.

Lee YS, Choi YH, Yoon IS, Kim TK, Ryu KH, Lee BY, Lee MG.

Biopharm Drug Dispos · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1002/bdd.737

Bibliografisk träff 2010-09-23

The effect of mirodenafil on the penile erection and corpus cavernosum in the rat model of cavernosal nerve injury.

Kim H, Sohn DW, Kim SD, Hong SH, Suh HJ, Lee CB, Kim SW.

Int J Impot Res · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/ijir.2010.19

Bibliografisk träff 2010-09-01

Efficacy and safety of mirodenafil in men taking antihypertensive medications.

Paick JS, Kim JJ, Kim SC, Moon KH, Min KS, Park K, Suh JK, Yang DY.

J Sex Med · multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1743-6109.2010.01926.x

Bibliografisk träff 2010-02-01

Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous and oral administration of mirodenafil to streptozotocin-induced diabetes mellitus rats.

Lee YS, Choi YH, Kim TK, Ryu KH, Lee BY, Lee MG.

Xenobiotica · research support, non-u.s. gov't; journal article · DOI 10.3109/00498250903380975

Bibliografisk träff 2010-01-01

Pharmacokinetics of mirodenafil, a new erectogenic, and its metabolite, SK3541, in rats: involvement of CYP1A1/2, 2B1/2, 2D subfamily, and 3A1/2 for the metabolism of both mirodenafil and SK3541.

Choi YH, Lee YS, Lee MG, Kim TK, Lee BY.

J Pharm Pharm Sci · research support, non-u.s. gov't; journal article · DOI 10.18433/j3688m

Bibliografisk träff 2009-09-01

Dose-dependent pharmacokinetics and first-pass effects of mirodenafil, a new erectogenic, in rats.

Choi YH, Lee YS, Bae SH, Kim TK, Lee BY, Lee MG.

Biopharm Drug Dispos · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1002/bdd.669

Bibliografisk träff 2008-11-13

Determination of mirodenafil and sildenafil in the plasma and corpus cavernous of SD male rats.

Lee SK, Kim Y, Kim TK, Im GJ, Lee BY, Kim DH, Jin C, Yoo HH.

J Pharm Biomed Anal · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jpba.2008.11.004

Bibliografisk träff 2008-11-01

The penile erection efficacy of a new phosphodiesterase type 5 inhibitor, mirodenafil (SK3530), in rabbits with acute spinal cord injury.

Jung JY, Kim SK, Kim BS, Lee SH, Park YS, Kim SJ, Choi C, Yoon SI, Kim JS, Cho SD, Im GJ, Lee SM, Jung JW, Lee YS.

J Vet Med Sci · journal article · DOI 10.1292/jvms.70.1199

Bibliografisk träff 2008-01-01

Identification of cytochrome P450 enzymes responsible for N -dealkylation of a new oral erectogenic, mirodenafil.

Lee HS, Park EJ, Ji HY, Kim SY, Im GJ, Lee SM, Jang IJ.

Xenobiotica · journal article · DOI 10.1080/00498250701708521